James F Young - Net Worth and Insider Trading
James F Young Net Worth
The estimated net worth of James F Young is at least $863,933 dollars as of 2024-05-15. James F Young is the Director of Novavax Inc and owns about 64,090 shares of Novavax Inc (NVAX) stock worth over $863,933. Details can be seen in James F Young's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James F Young has not made any transactions after 2022-03-31 and currently still holds the listed stock(s).
Transaction Summary of James F Young
James F Young Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James F Young owns 1 companies in total, including Novavax Inc (NVAX) .
Click here to see the complete history of James F Young’s form 4 insider trades.
Insider Ownership Summary of James F Young
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NVAX | Novavax Inc | 2022-03-31 | director |
James F Young Latest Holdings Summary
James F Young currently owns a total of 1 stock. James F Young owns 64,090 shares of Novavax Inc (NVAX) as of March 31, 2022, with a value of $863,933.
Latest Holdings of James F Young
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NVAX | Novavax Inc | 2022-03-31 | 64,090 | 13.48 | 863,933 |
Holding Weightings of James F Young
James F Young Form 4 Trading Tracker
According to the SEC Form 4 filings, James F Young has made a total of 4 transactions in Novavax Inc (NVAX) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Novavax Inc is the sale of 12,500 shares on March 31, 2022, which brought James F Young around $919,750.
Insider Trading History of James F Young
- 1
James F Young Trading Performance
GuruFocus tracks the stock performance after each of James F Young's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James F Young is 37.62%. GuruFocus also compares James F Young's trading performance to market benchmark return within the same time period. The performance of stocks bought by James F Young within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James F Young's insider trading performs compared to the benchmark.
Performance of James F Young
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 25.25 | | | | | |
| Relative Return to S&P 500(%) | 24.42 | | | | | |
James F Young Ownership Network
James F Young Owned Company Details
What does Novavax Inc do?
Who are the key executives at Novavax Inc?
James F Young is the director of Novavax Inc. Other key executives at Novavax Inc include President & R&D Filip Dubovsky , President & R&D Gregory M Glenn , and EVP & Chief Strategy Officer Elaine O'hara .
Novavax Inc (NVAX) Insider Trades Summary
Over the past 18 months, James F Young made no insider transaction in Novavax Inc (NVAX). Other recent insider transactions involving Novavax Inc (NVAX) include a net purchase of 6,000 shares made by Gregory M Glenn ,
In summary, during the past 3 months, insiders sold 0 shares of Novavax Inc (NVAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Novavax Inc (NVAX) were sold and 6,000 shares were bought by its insiders, resulting in a net purchase of 6,000 shares.
Novavax Inc (NVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Novavax Inc Insider Transactions
James F Young Mailing Address
Above is the net worth, insider trading, and ownership report for James F Young. You might contact James F Young via mailing address: One Medimmune Way, Gaithersburg Md 20878.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
